Marcum Wealth’s Vivani Medical VANI Stock Holding History

Marcum Wealth’s Portfolio VANI Stock Details VANI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-417	Closed	-$7K	–	107
2019 Q4	$7K	Buy	+417	New	+$8.18K	﹤0.01%	108

Other funds holding VANI

VVM

Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

WealthTrust Axiom Wayne, Pennsylvania $406M AUM 40.44% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

WEC

Winslow Evans & Crocker Boston, Massachusetts $528M AUM 30.99% 1-Year Est. Return

Marcum Wealth's VANI Position: Q1 2020 in Review

Marcum Wealth sold out of Vivani Medical (VANI) in Q1 2020, closing a stake of 417 shares — an estimated $7K sold.

Marcum Wealth first reported a position in VANI in Q4 2019 and held it in 1 quarter. The position peaked at $7K in Q4 2019. 21 funds tracked by Wall St. Rank hold VANI as of Q1 2020.

Marcum Wealth reported no remaining Vivani Medical position as of Q1 2020 after selling out during the quarter.
Marcum Wealth sold 417 Vivani Medical shares in Q1 2020, an estimated $7K.
Marcum Wealth first reported a position in Vivani Medical in Q4 2019 and held it in 1 quarter.
Marcum Wealth's Vivani Medical position peaked at $7K in Q4 2019.
21 funds tracked by Wall St. Rank held Vivani Medical as of Q1 2020.

Based on Marcum Wealth's 13F filing for Q1 2020, filed 14 May 2020.